期刊文献+

中国株HIV-1核心蛋白Gag核酸疫苗的构建与表达 被引量:5

Construction and expression of HIV-1_(CN) Gag DNA vaccine
原文传递
导出
摘要 目的 构建含HIV 1中国流行株B亚型核心蛋白Gag基因的真核表达质粒 ,并在体外进行表达和鉴定。方法 将Gag基因插入到核酸疫苗载体质粒pVAX1中 ,构建真核表达质粒 pVAXGAG。用脂质体法 ,将重组质粒转染入Hela细胞后进行表达产物的检测。结果间接免疫荧光检测显示 ,转染重组质粒的细胞表面有绿色荧光。Westernblot和DotELISA分析显示 ,重组质粒转染细胞的裂解物中存在表达的Gag蛋白。 结论构建的核酸疫苗可在体外进行表达 。 Aim To construct the eukaryotic expression vector for HIV 1 CN core protein Gag gene and express it in vitro . Methods The recombinant expression vector pVAXGAG was constructed by inserting Gag gene into DNA vaccine vector pVAX1. The recombinant vector was transfected into Hela cell via liposome and the expressed product was detected by indirect immnuofluo rescence (IF),Western blot and Dot ELISA. Results The indirect IF showed green fluorescence on the membrane of transfected cells. Western blot and Dot ELISA demonstrated that expressed Gag protein existed in the lysate of Hela cells transfected by recombinant plasmid. Conclusion The constructed DNA vaccine can be expressed in vitro , and the expressed protein can react specifically with anti HIV P24 mAb.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2002年第6期531-532,共2页 Chinese Journal of Cellular and Molecular Immunology
基金 国家杰出青年基金资助No .3 982 5 119
关键词 HIV-1 核心蛋白 核酸疫苗 脂质体法 HIV 1 core protein DNA vaccine expression
  • 相关文献

参考文献2

  • 1Sambrook J 金冬雁等(译).分子克隆实验指南(第2版)[M].北京:科学出版社,1992.16-68.
  • 2张应玖 金宁一 等.核酸疫苗的研究进展[J].细胞与分子免疫学杂志,2001,17:51-54.

共引文献3

同被引文献25

  • 1李子健,金宁一,张立树,江文正.人免疫缺陷病毒Ⅱ型核心蛋白DNA疫苗的实验免疫研究[J].免疫学杂志,2005,21(1):17-19. 被引量:2
  • 2成军 陈菊梅.白细胞介素18的研究进展[J].细胞和分子免疫学杂志,1999,15:1-3.
  • 3GRIEM H R. Plasma spectroscopy[M]. New York : McGraw - Hill, 1964.
  • 4CREMERS D A, RADZIEMSKI L J. Handbook of Laser -Induced Breakdown Spectroscopy [M]. Chichester: John Wilkey & Sons Ltd, 2006.
  • 5Wang B, E K Ugen, V Strikantan, et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1[J]. Proc Natl Acad Sci USA, 1993, 90(9): 4156-4160.
  • 6MacGregor RR, Boyer JD, Ugen KE, et al. First human trial of a DNA-Based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response[J]. J Infect Dis, 1998, 178(1): 92-100.
  • 7Stenger S, Modlin RL. Cytotoxic T cell responses to intracellular pathogens[J]. Curr Opin Immunol, 1998, 10(4): 471-475.
  • 8Wolff JA, Danko I . Direct gene transfer into muscle[J]. Vaccine, 1994, 12(16): 1499-1503.
  • 9Donnelly JJ, Ulmer JB, Liu MA. DNA vaccine[J]. Life Sci, 1997,60:163 - 172.
  • 10Schild GC, Minor PD. Human immunodeficiency virus and AIDS vaccine[J]. Lancet, 1990, 335:1081-1084.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部